« Back to Record
Citation APA

Neven, P., Paridaens, R., Pelgrims, G., Martens, M., Bols, A., Goeminne, J. C., Vindevoghel, A., Demol, J., Stragier, B., De Greve, J., Fontaine, C., Van Den Weyngaert, D., Becquart, D., Borms, M., Cocquyt, V., Van Den Broecke, R., Selleslags, J., Awada, A., Dirix, L. Y., Van Dam, P., Azerad, M.-A., Vandenhoven, G., Christiaens, M. R., & Vergote, I. (2008). Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study. Breast cancer research and treatment, 109(1), 59-65. doi:10.1007/s10549-007-9628-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53571

Neven, P., Paridaens, R., Pelgrims, G., Martens, M., Bols, A., Goeminne, J. C., Vindevoghel, A., Demol, J., Stragier, B., De Greve, J., Fontaine, C., Van Den Weyngaert, D., Becquart, D., Borms, M., Cocquyt, V., Van Den Broecke, R., Selleslags, J., Awada, A., Dirix, L. Y., Van Dam, P., Azerad, M.-A., Vandenhoven, G., Christiaens, M. R., & Vergote, I. (2008). Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study. Breast cancer research and treatment, 109(1), 59-65. doi:10.1007/s10549-007-9628-2